Skip to main content
. 2014 Dec 16;9:1–11. doi: 10.2147/DDDT.S72572

Figure 3.

Figure 3

Mean rifaximin concentration-time (A) and cumulative urinary excretion (B) profiles following administration of a single 200 mg dose of amorphous rifaximin or rifaximin-α to healthy volunteers. Each point or column represents the mean ± standard error of the mean (vertical lines) obtained from 12 subjects.